Hsa-miR-330-3p has been demonstrated to regulate cellular motility by down regulating SP1 in prostate cancer cells [75], and proliferation by reducing CDC42 levels in colorectal cancer [76]. This evidence concerns the gene CDC42 and Familial prostate cancer.